Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo
By:- Upendra Agrawal
1
2
Clinical Data Management (CDM) is a critical phase
in clinical research, which leads to generation of high-quality,
reliable, and statistically sound data from clinical trials.
Clinical Data Management assures collection, integration and
availability of data at appropriate quality and cost.
CDM encompasses the entry, verification, validation,
and quality control of data gathered during the conduct of
clinical trial
3
There are no of reason why CDM is needed as most important reason
are:
1. Clinical Data Management (CDM) is a critical phase in clinical research,
which leads to generation of high-quality, reliable, and statistically sound
data from clinical trials. This helps to produce a drastic reduction in time
from drug development to marketing.
2. Regulatory Agencies is dependent upon a trust that clinical trials data
presented are of sufficient integrity to ensure confidence in results &
conclusions presented by Pharma company and it is Important to
obtaining that trust is adherence to quality standards & practices hence .
4
1. Case report forms (CRFs) design
2. Database design
3. Database programming
4. 21 CFR part 11 compliant validation process
5. Loading, reconciliation and integration of external data
6. Medical coding
7. Status reporting
8. Forms management
9. Data entry and cleaning
10. Data locking
5
The Key members involved in Data Management:
 Clinical Data Manager
 Database Administrator
 Database Programmer
 Clinical Data Coordinator
 Clinical Data Associate
6
The clinical trial data gathered at the investigator site in the
CRF are stored in the CDMS & this system employ various
means to verify the data to reduce possibility of error due to
human entry.
Types of CDMS:
1. Paper based system
2. Electronic data capturing system
7
Paper based system
Electronic data capturing
system
 Data is entered to CDMS
from CRF
 Time consuming process
 Inexpensive
 DCF send in paper form to
the site
 Data is directly upload to
CDMS by investigator
 Time saving process
 expensive
 Electronic alert send to the
site if there is any problem
8
Once the data are uploaded by side then data validation
is done by data validation team if there is any
discrepancy then alert is send to the site to resolve it.
9
No
Yes
CRF
Manual data
Electronic
data
Raw data
A
Electronic data
to be combined?
Raw data
(Manual)
Get approval
Data capturing
A
Real time query
Are the
queries answered?
Yes
No
Data cleaning
1. Detecting & diagnosing errors
2. Editing incorrect data
3. Integrated data passage
4. Outlier determination
5. Robust estimation of analytical parameters
Clean data
Approval required
Can this data
be locked?
Yes
NoRepeat
Observation/
Omission
Locked data B
B
Locked Clean Data
Statistical analysis
required?
Yes
No
SAS Data Sets
Statistical Data Analysis
Tests of Hypotheses
Cohort Analyses
Results
Report
Data Summary,
Charts/Graphs
 The Integrity & quality of data being transferred from
trial subjects to a database system
 That the collected data is complete and accurate so that
results are correct
 That trial database is complete and accurate, and a true
representation of what took place in trial
 That trial database is sufficiently clean to support
statistical analysis, and its subsequent presentation and
interpretation
13
• India offers many advantages as a CDMS hub
• Cost
• Concentration of resources
• Expertise
• Comprehensive risk management databases, analysis, mitigation and
PV centers
• Consolidation of various databases (especially large ones)
• India’s IT sector is growing at ~25% per year thus maintaining
complex CDMSs at competitive costs in India is an added
advantage
• Abundant skilled personnel in all areas of CDM available
• Hub of almost all clinical trial activities in coming years
The ultimate goal of CDM is to assure that data support
conclusions drawn from research. Achieving this goal
protects public health and confidence in marketed
therapeutics.
15
 http://www.ncbi.nlm.nih.gov/
 clinical-data-management-training-gratisol-
labs
16
17
18

More Related Content

Clinical data management

  • 2. 2
  • 3. Clinical Data Management (CDM) is a critical phase in clinical research, which leads to generation of high-quality, reliable, and statistically sound data from clinical trials. Clinical Data Management assures collection, integration and availability of data at appropriate quality and cost. CDM encompasses the entry, verification, validation, and quality control of data gathered during the conduct of clinical trial 3
  • 4. There are no of reason why CDM is needed as most important reason are: 1. Clinical Data Management (CDM) is a critical phase in clinical research, which leads to generation of high-quality, reliable, and statistically sound data from clinical trials. This helps to produce a drastic reduction in time from drug development to marketing. 2. Regulatory Agencies is dependent upon a trust that clinical trials data presented are of sufficient integrity to ensure confidence in results & conclusions presented by Pharma company and it is Important to obtaining that trust is adherence to quality standards & practices hence . 4
  • 5. 1. Case report forms (CRFs) design 2. Database design 3. Database programming 4. 21 CFR part 11 compliant validation process 5. Loading, reconciliation and integration of external data 6. Medical coding 7. Status reporting 8. Forms management 9. Data entry and cleaning 10. Data locking 5
  • 6. The Key members involved in Data Management:  Clinical Data Manager  Database Administrator  Database Programmer  Clinical Data Coordinator  Clinical Data Associate 6
  • 7. The clinical trial data gathered at the investigator site in the CRF are stored in the CDMS & this system employ various means to verify the data to reduce possibility of error due to human entry. Types of CDMS: 1. Paper based system 2. Electronic data capturing system 7
  • 8. Paper based system Electronic data capturing system  Data is entered to CDMS from CRF  Time consuming process  Inexpensive  DCF send in paper form to the site  Data is directly upload to CDMS by investigator  Time saving process  expensive  Electronic alert send to the site if there is any problem 8
  • 9. Once the data are uploaded by side then data validation is done by data validation team if there is any discrepancy then alert is send to the site to resolve it. 9
  • 10. No Yes CRF Manual data Electronic data Raw data A Electronic data to be combined? Raw data (Manual) Get approval Data capturing
  • 11. A Real time query Are the queries answered? Yes No Data cleaning 1. Detecting & diagnosing errors 2. Editing incorrect data 3. Integrated data passage 4. Outlier determination 5. Robust estimation of analytical parameters Clean data Approval required Can this data be locked? Yes NoRepeat Observation/ Omission Locked data B
  • 12. B Locked Clean Data Statistical analysis required? Yes No SAS Data Sets Statistical Data Analysis Tests of Hypotheses Cohort Analyses Results Report Data Summary, Charts/Graphs
  • 13.  The Integrity & quality of data being transferred from trial subjects to a database system  That the collected data is complete and accurate so that results are correct  That trial database is complete and accurate, and a true representation of what took place in trial  That trial database is sufficiently clean to support statistical analysis, and its subsequent presentation and interpretation 13
  • 14. • India offers many advantages as a CDMS hub • Cost • Concentration of resources • Expertise • Comprehensive risk management databases, analysis, mitigation and PV centers • Consolidation of various databases (especially large ones) • India’s IT sector is growing at ~25% per year thus maintaining complex CDMSs at competitive costs in India is an added advantage • Abundant skilled personnel in all areas of CDM available • Hub of almost all clinical trial activities in coming years
  • 15. The ultimate goal of CDM is to assure that data support conclusions drawn from research. Achieving this goal protects public health and confidence in marketed therapeutics. 15
  • 17. 17
  • 18. 18